Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

The Brief Cognitive Behavioral Therapy Program: Reaching More Veterans with Depression

May 30, 2023

Takeaway: MyBrief Cognitive Behavioral Therapy (CBT) streamlines care for Veterans with depression who are at risk for suicide. The program has trained over 80 providers across 40 facilities and 4 VISNs. Providers have delivered MyBrief CBT to over 800 Veterans. Veterans typically receive 3-4 sessions of care and show significant reductions in depressive symptoms. Resources are available for VISNs, facilities, and providers to use the MyBrief CBT program.


Depression is a serious health condition that places tremendous burdens on patients and healthcare systems and is especially prevalent among Veterans. An estimated 21 million adults had at least one major depressive episode in 2020, representing 8% of the U.S. adult population.1 According to the Centers for Disease Control and Prevention (CDC), a significant risk factor for suicide is depression.

Cognitive behavioral therapy (CBT), consisting of 12 to 16 sessions, has been shown to be an efficacious treatment for depression. Brief CBT involves 3-6 sessions of care and is also effective but compresses clinical practices to improve access and reduce treatment burden on providers and patients.   

Brief CBT Testing and Initial Implementation

Through a series of multisite clinical trials supported by HSR&D, a team of investigators, in collaboration with clinical and operational partners, developed and tested a brief CBT approach for depression. Led by Jeffrey Cully, PhD, an investigator with HSR&D’s Center for Innovations in Quality, Effectiveness and Safety (IQuESt), the research team documented the effectiveness of brief CBT for Veterans while simultaneously developing strategies to help VA providers use the intervention in clinical settings.  Outcomes of these trials found brief CBT reduced depression symptoms and suicidal ideation among Veterans in primary care and VA Community Based Outpatient Clinics (CBOCs) and provided critical insights into the need for a multifaceted provider support program.2-4

MyBrief CBT for Depression in Frontline Practice

In 2019, the research team received HSR&D funding to increase the availability of brief CBT by training and supporting VA providers to deliver the program to Veterans. Marketed as MyBrief CBT for Depression, the program was introduced to mental health leaders in VISN 16 (South Central VA Healthcare) and VISN 17 (VA Heart of Texas Healthcare Network) and was rapidly adopted. Notably, the research team transitioned into the MyBrief CBT “national resource team” (NRT) to focus on partnerships, resources, and developmental opportunities to ensure providers and operational partners had support to use the program in their clinical settings.

MyBrief CBT for Depression Resources

MyBrief CBT

To improve adoption and scaling, the NRT created a suite of resources and support strategies to help providers, facilities, and VISNs.5 Resources include:

  • Clinical Program Materials for Providers and Patients (e.g., manuals and workbooks with Veteran-centric vignettes and examples): available through the South Central MIRECC (Mental Illness Research Education Clinical Centers).
  • Virtual Provider Training and Curriculum: Five 60-minute webinars available through VA’s Talent Management System (TMS; search under MyBrief CBT). Accredited education available.
  • Real-time data dashboard that allows providers, facilities, and VISNs to track MyBrief CBT use and Veteran outcomes (VA access only).
  • MyBrief CBT national note template (currently in final stages of pilot testing).
  • Support from the MyBrief CBT National Resource Team. The NRT coordinates and facilitates training and consultation at the local and regional level, which includes train-the-trainer and champion programs to allow sites to “own” the program.


MyBrief CBT is effective for use in VA clinical settings. More than 80 providers have been trained across 40+ VA facilities and 4 VISNs. Providers have engaged over 800 Veterans in care and have delivered more than 3,000 sessions of MyBrief CBT. Veterans receiving MyBrief CBT have experienced notable improvements in depressive symptoms.


The MyBrief CBT program, developed specifically for Veterans through HSR&D funding, has received robust support from clinical providers and operational partners, has increased access to psychotherapy services in four VISNs, and has been shown to be particularly effective at decreasing depression symptoms in Veterans. VISNs or facilities interested in the MyBrief CBT program can reach the NRT at VHAHOUMyBriefCBT_NRT@VA.GOV.


VISNs 8 (Sunshine Healthcare Network), 16, 17, and 19 (Rocky Mountain Network). South Central MIRECC, Rocky Mountain MIRECC, and VA’s Office of Rural Health (ORH).


  1. Major Depression. National Institute of Mental Health (NIMH).
  2. Cully J, Stanley M, Petersen N, et al. Delivery of brief cognitive behavioral therapy for medically ill patients in primary care: A randomized clinical trial. Journal of General Internal Medicine. 2017;32(9):1014-1024.
  3. Ecker A, Johnson A, Sansgiry S, et al. Brief cognitive behavioral therapy reduces suicidal ideation in Veterans with chronic illness. General Hospital Psychiatry. May-June, 2019;58:27-32.
  4. Johnson A, Ecker A, Barrera T, et al. Increasing the impact of randomized controlled trials: An example of a hybrid effectiveness-implementation design in psychotherapy research. Translational Behavioral Medicine. August 7, 2020;10(3):629-636.
  5. Boykin D, Wray L, Funderburk J, et al. Leveraging the ExpandNet framework and operational partnerships to scale-up brief cognitive-behavioral therapy in VA primary care clinics. Journal of Clinical and Translational Science. July 2022;20(6)e95.

Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.